Cummins Elects Jennifer Rumsey to its Board of Directors
COLUMBUS, Ind.–(BUSINESS WIRE)–Today, Cummins Inc. (NYSE: CMI) announced Jennifer Rumsey, its President and Chief Operating…
News
Hayward Holdings Announces Fourth Quarter and Full Year 2021 Earnings Release and Conference Call Date
BERKELEY HEIGHTS, N.J.–(BUSINESS WIRE)–Hayward Holdings, Inc. (NYSE: HAYW) a global designer, manufacturer, and marketer of…
KB Home Announces the Grand Opening of Mission Villas, a New Townhome Community in San Marcos, California
Homebuilder’s latest community offers new townhomes in a popular San Diego County location, affordably priced…
Generational Capital Markets Advises Cloud 9 Services in Its Sale to Canopy Capital Partners
DALLAS–(BUSINESS WIRE)–Generational Capital Markets, Member FINRA/SIPC and a leading mergers and acquisitions advisor for privately-held…
ProQR Announces Top-Line Results from Phase 2/3 Illuminate Trial of Sepofarsen in CEP290-mediated LCA10
Study did not meet primary endpoint nor notable secondary endpoints – no benefit observed in…
Akari Therapeutics to Present at BIO CEO & Investor Conference
NEW YORK and LONDON, Feb. 11, 2022 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX),…
Prelude Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
WILMINGTON, Del., Feb. 11, 2022 (GLOBE NEWSWIRE) — Prelude Therapeutics Inc. (NASDAQ: PRLD), a clinical-stage…
Eliem Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
SEATTLE and CAMBRIDGE, United Kingdom, Feb. 11, 2022 (GLOBE NEWSWIRE) — Eliem Therapeutics, Inc. (Nasdaq:…
Immunocore to present at the SVB Leerink Global Healthcare Conference
Immunocore to present at the SVB Leerink Global Healthcare Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn….
Sio Gene Therapies Announces Corporate Updates and Fiscal Third Quarter 2021 Financial Results
Company prioritizing industry-leading clinical-stage programs, AXO-AAV-GM1 and AXO-AAV-GM2, the first potential disease-modifying therapies for GM1…
IsoPlexis to Participate in Three Upcoming Investor Conferences
BRANFORD, Conn., Feb. 11, 2022 (GLOBE NEWSWIRE) — IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell…
Talaris Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
BOSTON and LOUISVILLE, Ky., Feb. 11, 2022 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc. (Nasdaq: TALS),…
Newell Brands Announces Fourth Quarter and Full Year 2021 Results
Q4 Net Sales Growth 4.3%; Core Sales Growth 5.8% Q4 Diluted EPS $0.22; Normalized Diluted…
Cleveland-Cliffs Reports Full-Year and Fourth-Quarter 2021 Results and Announces $1 Billion Share Repurchase Program
Record annual revenue of $20.4 billion Record annual net income of $3.0 billion Record annual…
Danimer Scientific Announces Date for Fourth Quarter and Full Year 2021 Results
BAINBRIDGE, Ga.–(BUSINESS WIRE)–Danimer Scientific (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics…
Syniverse to Pursue Alternative Transaction with Twilio Following Termination of Business Combination Agreement with M3-Brigade Acquisition II Corp.
TAMPA, Fla.–(BUSINESS WIRE)–Syniverse®, the “world’s most connected company®” and a premier global technology provider of…
New Data Presented at ISC 2022 Further Validates Impact of the Viz Platform for Intelligent Care Coordination in the Real World
SAN FRANCISCO & NEW ORLEANS–(BUSINESS WIRE)–#AI–Data from several new studies presented this week at the…
IAA, Inc. Announces Fourth Quarter and Full Year Fiscal 2021 Financial Results
Delivers Record 2021 Results Introduces Full-Year 2022 Outlook WESTCHESTER, Ill.–(BUSINESS WIRE)–IAA, Inc. (NYSE: IAA) today…
The Arena Group Announces Pricing of $30,000,000 Public Offering, Following February 9, 2022 Uplisting to the NYSE American
NEW YORK–(BUSINESS WIRE)–The Arena Group Holdings, Inc., formerly known as theMaven, Inc. (NYSEAMERICAN: AREN) (the…
Protolabs Reports Financial Results for the Fourth Quarter and Full Year 2021
Revenue of $123.6 million in the Fourth Quarter of 2021, an increase of 18% year-over-year…